Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.
Jenike
M A
MA
Harvard Medical School and Massachusetts General Hospital, Boston 02114.
Baer
L
L
Summergrad
P
P
Weilburg
J B
JB
Holland
A
A
Seymour
R
R
D000328:Adult; D000553:Ambulatory Care; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D010919:Placebos; D011569:Psychiatric Status Rating Scales
D010919:Placebos; D002997:Clomipramine